Impact of Staphylococcus Aureus enterotoxin on pulmonary inflamation
Impact of Staphylococcus Aureus enterotoxin on pulmonary inflamation
批准号:
8424005
负责人:
Anthony T Vella
金额:
$38.33万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2018-04-30
关键词:
AcuteAcute Lung InjuryAddressAdult Respiratory Distress SyndromeAerosolsAlveolitisAreaBiologicalBreathingBronchoalveolar Lavage FluidCellsCenters for Disease Control and Prevention (U.S.)CharacteristicsDataDiseaseDistressEnterotoxinsGoalsHourHumanImmune responseIndividualInflammationInflammatoryInjuryInstructionLeadLungLung InflammationLung diseasesMediator of activation proteinMiningMusNatureOutcomePathologyPathway interactionsPatientsPeptide HydrolasesPeptidesPlayPneumoniaPopulationProcessProductionPropertyProteinsProteomicsResearchRespiratory SystemRespiratory tract structureRoleShockSignal TransductionStagingStaphylococcus aureusStructureSuperantigensT-Cell ActivationT-LymphocyteTestingTissuesToxic Shock SyndromeUnited States National Institutes of HealthVascular Permeabilitiesbiodefensecellular targetingcytokinemicrobialpathogenrespiratoryresponseweapons
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The biodefense agent Staphylococcus aureus enterotoxin is regarded as a superantigen (SAg) because it is
not processed as conventional peptide and is an incredibly powerful T cell stimulant. Enterotoxins can cause
lethal toxic shock in humans and intentional aerosol exposure of S. aureus enterotoxin has the potential to
incapacitate large groups of people. The consequences of such a biological attack can lead to severe
respiratory illness in exposed individuals. Notwithstanding, certain pulmonary diseases in human patients
have recently been associated with the presence of SAg, and stimulation of T cells with SAg in the
respiratory tract drives an inflammatory cascade resulting in severe pathological outcomes in the lung. This
includes pulmonary inflammation, vascular permeability and alveolitis. Although this pathogenic response
involves SAg-specific T cells, the underlying mechanism of disease initiation and mediators of lung
inflammation are unclear. Our data show that innate cell recruitment and their activation in lung are
dependent upon TCR Vp bearing T cells and occurs rapidly after exposure. A new finding clearly
demonstrates this point since only a few hours after SAg inhalation y.ST cells begin to synthesize I L-17a.
Unexpectedly, 1L-I7a production was shown to be dependent on the presence of TCR Vp T cells. The role
of SAg-specific IT cell sub-populations involved in controlling Y 5 T cell activation will be investigated in Aim 1.
A consequence of early innate cell activation is pulmonary tissue injury, and by proteomic mining of
bronchoalveolar lavage fluid we detected intracellular proteins that may have come from damaged lung
cells. In Aim 2 we will purify and characterize a protease-sensitive factor that we detected in
bronchoalveolar lavage fluid which has characteristics of a DAMP. Our goal is to identify this molecule and
validate its ability to stimulate cytokine release by defining its cellular target and signaling properties. Lastly,
an outcome of DAMP activity is intensification of inflammation, and in this regard our new data show a
potential role for the IL-33 pathway. Aim 3 will test how S. aureus enterotoxin inhalation impacts the IL-33
pathway and if it can be modulated to develop countermeasures against a pulmonary crisis.
RELEVANCE (See instructions):
The study of enterotoxins released from Staphylococcus aureus is an important area of research due to the
role these proteins play in inducing very strong immune responses. The nature ofthese proteins allows T
cells to respondlvigorously which can lead to serious illness in people for which there is no clear treatment.
This proposal will address important issues centered on understanding the initiation of these responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MiR-150 regulated adiose tissue B cells in obesity
-
批准号:10571689
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Anthony T Vella
-
依托单位:
MiR-150 regulated adiose tissue B cells in obesity
-
批准号:10357914
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Anthony T Vella
-
依托单位:
IRAK4 and Systemic Lupus Erythematosus
-
批准号:9920669
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2018
-
负责人:Anthony T Vella
-
依托单位:
IRAK4 and Systemic Lupus Erythematosus
-
批准号:10118270
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2018
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6702215
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:9055615
-
项目类别:
-
资助金额:$266.91万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:7023905
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6614049
-
项目类别:
-
资助金额:$13.59万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:8661689
-
项目类别:
-
资助金额:$266.08万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:8414902
-
项目类别:
-
资助金额:$252.35万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:9268551
-
项目类别:
-
资助金额:$266.75万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:7184441
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6846020
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the mechanism of 4-1BB costimulation
-
批准号:6506130
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2002
-
负责人:Anthony T Vella
-
依托单位:
PROINFLAMMATORY CYTOKINES BLOCK T CELL DEATH IN VIVO
-
批准号:6541284
-
项目类别:
-
资助金额:$25.85万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
PROINFLAMMATORY CYTOKINES BLOCK T CELL DEATH IN VIVO
-
批准号:6510813
-
项目类别:
-
资助金额:$27.65万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:7447415
-
项目类别:
-
资助金额:$33.72万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:7256916
-
项目类别:
-
资助金额:$34.37万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
How Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:8918772
-
项目类别:
-
资助金额:$5.78万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
How Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:8628022
-
项目类别:
-
资助金额:$38.26万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
海外基金